Theranos Closes Blood-Testing Labs to Focus on New Product

Updated on
  • Holmes will stay on as CEO with ‘new executive team’
  • Blood testing company will focus on next ‘miniLab’ product

Elizabeth Holmes.

Photographer: David Paul Morris/Bloomberg

Embattled startup Theranos Inc. will close its blood-testing labs and fire about 340 workers, shifting its focus to an experimental technology following months of run-ins with regulators and questions about whether its existing products work.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.